Two years on from the discovery of the first treatment for COVID-19 we tell the story of how it has saved millions of lives around the globe. We look at the study that found it, and what that means for future diseases.
The trial that saved lives
Two years on: the COVID-19 treatment that saved millions Two years ago, the discovery of the first lifesaving treatment for COVID-19, was announced to the world. In the following nine months, dexamethasone, saved an estimated one million lives worldwide, including 22,000 in the UK.
In Depth: the RECOVERY trial by the researchers who worked on it Dexamethasone was announced as effective one lunchtime and four hours later was protocol in all NHS hospitals. Read the inside story of the trial that discovered it, from the people who were working on it: ‘To a young researcher like me, that day felt like being part of history. It was a gift from the UK to the world.’
What RECOVERY means for the future of clinical trials As the COVID-19 situation in the UK changes, so is RECOVERY changing. In this piece, Professor Richard Haynes explains how the study is being expanded globally, to help those countries where vaccine coverage is less good.
WATCH: Dexamethasone saved my life
John Hanna was on a ventilator and seriously ill when his wife was asked if he’d take part in the RECOVERY trial. `It’s as if I am watching him die in front of me and there’s nothing I can do,’ his wife Esther recalls. The trial allocated him Dexamethasone – and the results were dramatic. Watch John and Esther’s story here.
COVID-19 immunity study reinforces the need for booster jabs An MRC-supported study led by Glasgow Caledonian University, found that double-jabbed people who had previously been infected had greater protection against the virus, standing at over 90% after two doses. This protection remained strong over a year after infection.
Drones deliver urgent medical supplies to Scilly Isles Drones developed in Southampton and Cornwall, supported by ISCF, carried PPE and COVID-19 testing kits to the Isles of Scilly. This has proved they can be rapidly mobilised to deliver time-sensitive supplies like vaccines.